Allosteric cross-talk in chromatin can mediate drug-drug synergy
Allostery and drug-drug synergism can yield potential novel therapies with existing molecules. Here, the authors provide evidence that two unrelated drugs have increased cytotoxicity in cancer cells, which coincides with increased formation of chromatin adducts.
Enregistré dans:
Auteurs principaux: | Zenita Adhireksan, Giulia Palermo, Tina Riedel, Zhujun Ma, Reyhan Muhammad, Ursula Rothlisberger, Paul J. Dyson, Curt A. Davey |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9d1b4c81d2d84ca2b30e46381f058d95 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Nucleosome acidic patch-targeting binuclear ruthenium compounds induce aberrant chromatin condensation
par: Gabriela E. Davey, et autres
Publié: (2017) -
Near-atomic resolution structures of interdigitated nucleosome fibres
par: Zenita Adhireksan, et autres
Publié: (2020) -
Optimal drug synergy in antimicrobial treatments.
par: Joseph Peter Torella, et autres
Publié: (2010) -
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
par: Per Plenge, et autres
Publié: (2021) -
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
par: Ingrid Langer, et autres
Publié: (2021)